HSP47 Modulates A-beta Levels in Alzheimer's Disease
Author Information
Author(s): Bianchi Federico T., Camera Paola, Ala Ugo, Imperiale Daniele, Migheli Antonio, Boda Enrica, Tempia Filippo, Berto Gaia, Bosio Ylenia, Oddo Salvatore, LaFerla Frank M., Taraglio Stefano, Dotti Carlos G., Di Cunto Ferdinando
Primary Institution: University of Torino
Hypothesis
Does the collagen chaperone HSP47 interact with APP and affect the levels of extracellular beta-amyloid peptides?
Conclusion
HSP47 is identified as a new interactor of APP that can reduce the levels of secreted A-beta peptides.
Supporting Evidence
- HSP47 accumulates in amyloid deposits of mouse models and some AD patients.
- HSP47 can physically interact with APP and is relocalized by APP overexpression.
- Reducing HSP47 expression or activity decreases secreted A-beta levels.
Takeaway
HSP47 is a protein that helps in the formation of collagen and is found in the brain. It can affect the levels of a harmful substance related to Alzheimer's disease.
Methodology
The study used coexpression analysis, immunoprecipitation, and ELISA to investigate the interaction between HSP47 and APP and its effect on A-beta levels.
Limitations
The study primarily used cell lines and mouse models, which may not fully represent human Alzheimer's disease pathology.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website